|
|
Volumn 359, Issue 4, 2008, Pages 426-427
|
|
Telmisartan, Ramipril, or both in patients at high risk of vascular events [5]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RAMIPRIL;
TELMISARTAN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
BENZIMIDAZOLE DERIVATIVE;
BENZOIC ACID DERIVATIVE;
BLOOD PRESSURE;
BLOOD PRESSURE MONITORING;
CARDIOVASCULAR DISEASE;
CAUSE OF DEATH;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DRUG WITHDRAWAL;
HEART FAILURE;
HEART INFARCTION;
HIGH RISK PATIENT;
HOSPITALIZATION;
HUMAN;
HYPERKALEMIA;
HYPOTENSION;
LETTER;
MONOTHERAPY;
MORTALITY;
PRIORITY JOURNAL;
STROKE;
ANGIONEUROTIC EDEMA;
COUGHING;
DRUG TOLERABILITY;
FATALITY;
HEART LEFT VENTRICLE FAILURE;
HYPERTENSION;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
NOTE;
DIABETES MELLITUS;
ANGIOEDEMA;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BENZIMIDAZOLES;
BENZOATES;
CARDIOVASCULAR DISEASES;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPOTENSION;
RAMIPRIL;
CAUSE OF DEATH;
DIABETES MELLITUS;
|
|
EID: 47949092803
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc081065 Document Type: Letter |
|
Times cited : (27)
|
|
References (1)
|
